
So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

